Trial Details
COMPLETEDBasic Information
| Clinical ID | c752 |
|---|---|
| Identifier | NCT05570006 |
| Trial Title | Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: ABBV-668 |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Chula Vista |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-03-16 |
|---|---|
| Primary Completion Date | 2024-12-23 |
| Completion Date | 2024-12-23 |